Clinical Trials
Inceptua and Bendalis enter into an exclusive oncology medicine supply agreement for clinical trials
The global pharmaceutical company and service partner Inceptua Group (previously Multipharma GmbH) and Bendalis GmbH – German manufacturer of generic oncology drugs and special...
Clinical Trials
ERYTECH Announces Publication of its Phase 2b Trial of Eryaspase in Metastatic Pancreatic Cancer in the European Journal of Cancer
ERYTECH Pharma a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announced that the full results from...
Drug Research
Chi-Med Announces Surufatinib Granted FDA Orphan Drug Designation for Pancreatic Neuroendocrine Tumors
Hutchison China MediTech Limited announces that the U.S. FDA has granted Orphan Drug designation to surufatinib for the treatment of pancreatic neuroendocrine tumors.
“NET is...
Articles
New furnace for the innovative and sustainable production of clear-glass containers for solid and liquid drugs
Gerresheimer in Essen produces many millions of glass containers for the pharmaceutical industry every year. The long-established company has recently completed the routine renovation...
Packaging & Labelling
Turkish Cargo expands the Pharma Corridor in its wide flight network
Turkish Cargo, the fastest growing global air cargo brand thanks to its wide flight network, keeps bringing health to the world by carrying pharmaceuticals...
Drug Research
Bayer and Dewpoint Therapeutics partner to research new treatments for cardiovascular and gynecological diseases
Bayer and Dewpoint Therapeutics, a biotechnology company with sites in Boston and Dresden, Germany, announced an option, research and license agreement worth up to...
Industry Reports
Novartis to buy The Medicines Company for $9.7bn
Novartis has signed a definitive agreement to acquire US-based The Medicines Company for a total consideration of $9.7bn, or $85 per share.
The deal value...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read